Pradeep Vaishnav

Sanofi-Aventis India Ltd. engages in the research, production and distribution of pharmaceutical products. It provides medicines for the treatment of patients in several therapeutic areas such as cardiovascular, thrombotic diseases, metabolic disorders, oncology and disorders of the central nervous system. The company is headquartered in Mumbai, India.

Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India.